This startup wants to build a needle-free CGM using nanotechnology
Graphwear recently raised $20.5 million, which it plans to use to develop a CGM that uses nanotechnology to measure blood glucose levels.
Graphwear recently raised $20.5 million, which it plans to use to develop a CGM that uses nanotechnology to measure blood glucose levels.
Rune Labs developed software that aggregates brain data, providing insights for clinical care and clinical research. Health systems are starting to adopt the technology, and the startup has now raised $22.8 million to grow that part of the business while also expanding use of the technology in drug development.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Combining the two companies would allow patients to access genetic testing and their health records in one place, and make it easier for Invitae to collect and organize health records.
The startup, founded by several former Trulia executives, builds software to help healthcare providers with administrative tasks, including scheduling, registration and price transparency.
Telehealth startup Genome Medical recently raised $60 million in funding led by Casdin Capital. It’s using part of the funds to acquire GeneMatters, which would add more genetic counselors to its staff.
The startup is working with Curebase to launch five clinical trials to test its VR-based therapeutic for chronic pain. They plan to enroll a total of more than 2,000 people.
The two companies will merge to form Headspace Health, which will combine Headspace’s many meditation and wellness exercises with Ginger’s coaching and therapy services. The combined company will have more than 800 employees and a $3 billion valuation.
The startup, which is focused on letting patients share their health records for rare disease research, plans to use the funds to launch 100 rare disease programs.
Ginger, a startup that provides therapy, coaching and other mental health services through an app, is expanding its service to teens ages 13-17. The company plans to roll out the service to some of its members starting next month.
Eli Lilly is partnering with startup Verge Genomics in a move intended to add ALS drugs to its neuroscience pipeline. To date, Verge’s artificial intelligence technology has produced programs internal programs in ALS, Parkinson’s, and frontotemporal dementia.
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.
Intellihealth has developed software that puts patients on a personalized program to lose weight. The startup was named by judges as the winner in the health IT track during the recent MedCity News INVEST Precision Medicine conference.
DrChrono, one of the first companies to build out a mobile-friendly EHR, raised $12 million in funding. The startup plans to use the funds to build out its telehealth platform.
Primary care startup One Medical is buying Iora Health for $2.1 billion. The deal will give One Medical a bigger geographic footprint, and crucially, a bigger presence among people covered by Medicare.
Doximity, the “LinkedIn for physicians,” is preparing for an IPO. In an unusual move, it’s setting aside a portion of its shares for some of its users.
FDA authorization of the Covid-19 antibody drug from Vir Biotechnology and GlaxoSmithKline adds a third antibody drug for treating early cases of the disease that are at risk of progressing to hospitalization. The companies say they plan to launch the drug, named sotrovimab, “in coming weeks.”